Literature DB >> 9212110

Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance.

S W Ma1, D L Zhao, Z Q Yin, R Mukherjee, B Singh, H Y Qin, C R Stiller, A M Jevnikar.   

Abstract

Oral administration of protein can induce antigen-specific immune hyporesponsiveness. However, the utility of oral tolerance to autoantigens in the treatment of autoimmune diseases may be limited when candidate autoantigens cannot be produced by conventional systems in quantities sufficient for clinical studies. Plants may be ideally suited for this purpose, as they can synthesize, glycosylate and assemble mammalian proteins to provide huge quantities of relatively low cost soluble proteins. Furthermore, edible transgenic plants could provide a simple and direct method of autoantigen delivery for oral tolerance. Therefore, the aim of this study was to determine whether a transgenic plant expression system was capable of synthesizing the diabetes-associated autoantigen, glutamic acid decarboxylase (GAD) in an immunogenic form and whether the oral administration of an autoantigen expressed by a plant could directly induce protective immune responses in a mouse model of diabetes. We show that a GAD-expressing transgenic plant, given as a dietary supplement, inhibits the development of diabetes in the non-obese diabetic (NOD) mouse.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9212110     DOI: 10.1038/nm0797-793

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  31 in total

Review 1.  Immune mechanisms that regulate susceptibility to autoimmune type I diabetes.

Authors:  B Singh; T L Delovitch
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

2.  Expression of cholera toxin B subunit and the B chain of human insulin as a fusion protein in transgenic tobacco plants.

Authors:  Dora Li; Jennifer O'Leary; Yan Huang; Norman P A Huner; Anthony M Jevnikar; Shengwu Ma
Journal:  Plant Cell Rep       Date:  2005-12-02       Impact factor: 4.570

Review 3.  Oral tolerance and the treatment of rheumatoid arthritis.

Authors:  H L Weiner; Y Komagata
Journal:  Springer Semin Immunopathol       Date:  1998

Review 4.  Oral tolerance in disease.

Authors:  P Garside; A M Mowat; A Khoruts
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

5.  Detection of glutamic acid decarboxylase-activated T cells with I-Ag7 tetramers.

Authors:  C P Liu; K Jiang; C H Wu; W H Lee; W J Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

Review 6.  Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.

Authors:  Kwang-Chul Kwon; Dheeraj Verma; Nameirakpam D Singh; Roland Herzog; Henry Daniell
Journal:  Adv Drug Deliv Rev       Date:  2012-10-23       Impact factor: 15.470

7.  Improved in planta expression of the human islet autoantigen glutamic acid decarboxylase (GAD65).

Authors:  Linda Avesani; Alberto Falorni; Giovanni Battista Tornielli; Carla Marusic; Andrea Porceddu; Annalisa Polverari; Claudia Faleri; Filippo Calcinaro; Mario Pezzotti
Journal:  Transgenic Res       Date:  2003-04       Impact factor: 2.788

8.  Widespread expression of an autoantigen-GAD65 transgene does not tolerize non-obese diabetic mice and can exacerbate disease.

Authors:  L Geng; M Solimena; R A Flavell; R S Sherwin; A C Hayday
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

9.  Mucosal tolerance to prevent type 1 diabetes: can the outcome be improved in humans?

Authors:  Arno Hanninen; Leonard C Harrison
Journal:  Rev Diabet Stud       Date:  2004-11-10

Review 10.  Modulating the Th1/Th2 balance in inflammatory arthritis.

Authors:  B Müller; U Gimsa; N A Mitchison; A Radbruch; J Sieper; Z Yin
Journal:  Springer Semin Immunopathol       Date:  1998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.